News • Blog
Sexual health and LGBT population
Living with HIV
Post-exposure prophylaxis (PEP)
Studies indicate that viral suppression through a daily dose of valacyclovir (Valtrex) could reduce the spread of symptomatic herpes by more than 50%. While these results are noteworthy, further research is needed.
Research to develop a vaccine showed that preventive vaccines against herpes were effective in reducing by 70% the spread of the virus to women who were free of both oral and genital herpes. For men, however, no change was observed. The reason for these diverging results remains unknown. The next study involves 7,500 female subjects who test negative for HSV-1 and HSV-2, and are in a monogamous relationship with a partner who tests positive for HSV-2.
Ask your doctor for further details.